ArticleScientific reports2026
Phytochemical composition and antimicrobial efficacy of Nigerian polyherbal formulations against antibiotic-resistant micro-organisms.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- 1,8-Cineole Potentiates the Antibacterial Activity of Amoxicillin/Clavulanic Acid Against an ESBL-ProducingPharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial infections are prevalent in developing nations such as Nigeria, contributing significantly to poverty and mortality rates. Current therapeutic interventions are increasingly facing resistance from these pathogens. Nevertheless, natural products offer potential solutions to the challenges posed by pathogenic diseases. This study evaluates the methanolic efficacy of two plant extract formulations (BF1 and BF2) at varying concentrations (100 mg/mL, 125 mg/mL, and 150 mg/mL) to assess their antimicrobial activities against selected pathogens and conduct phytochemical screening. The phytochemical analysis identified the presence of flavonoids, alkaloids, glycosides, saponins, and terpenoids in both extracts, while tannins and phenolics were absent. Both extract formulations inhibited the growth of Bacillus subtilis, Enterobacter aerogenes, and Pseudomonas aeruginosa, with inhibition zones ranging from 7 mm to 21 mm across all concentrations. Also, the growth of Penicillium sp. and Aspergillus flavus was inhibited, with zones ranging from 7 mm to 15 mm. The Kruskal-Wallis' test results indicated significant differences among the groups, with gentamicin demonstrating a notably higher mean rank. Ultimately, the findings suggest that although gentamicin and ketoconazole exhibited superior activity, both plant extract formulations hold promise as potential alternative antimicrobial sources, thereby contributing to the combat against antibiotic resistance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.